Skip to content

XBIT - XBiotech Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchX

XBiotech Inc

XBIT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

X

XBITXBiotech Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.61
52-wk low: $2.09
Prev close: $2.92
Mkt cap: $70.4M
Beta: 0.85
P/S: 12.2x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$1.5M

MI
Millennium
Israel Englander · Q2 2026 13F
$182K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $70M

Valuation

P/S12.23
P/B0.54

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: XBIT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $70.43M
Beta: 0.85

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-29.9%

$96K

position

SQ

Squarepoint

Q2 2026 13F

$80K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for XBIT

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-29.9%

ROA-19.3%

Growth

Beta0.85